Disclosures for "Transcranial Alternating Current Stimulation as a Potential Remyelinating Therapy for Multiple Sclerosis"
-
Dr. Scheinok has received personal compensation in the range of $0-$499 for serving as a sponsoree for a scientific congress with Merck.
-
Prof. De Bundel has nothing to disclose.
-
Prof. Van Schependom has nothing to disclose.